Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$1.09B |
| 3 |
Wells Fargo
WFC
|
+$651M |
| 4 |
ConocoPhillips
COP
|
+$595M |
| 5 |
UnitedHealth
UNH
|
+$509M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 2 |
KKR & Co
KKR
|
+$937M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$907M |
| 4 |
CRH
CRH
|
+$630M |
| 5 |
Meta Platforms (Facebook)
META
|
+$615M |
Sector Composition
| 1 | Technology | 18.66% |
| 2 | Healthcare | 14.24% |
| 3 | Financials | 12.05% |
| 4 | Industrials | 11.02% |
| 5 | Consumer Discretionary | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Ball Corp
BALL
$13.9B
| $9.83M | ﹤0.01% |
163,727
+83,713
| +105% | +$5.02M |
|
1377
Corcept Therapeutics
CORT
$7.68B
| $9.82M | ﹤0.01% |
302,301
-250,706
| -45% | -$8.15M |
|
1378
AGCO
AGCO
$8.13B
| $9.8M | ﹤0.01% |
100,153
+63,434
| +173% | +$6.21M |
|
1379
Solid Biosciences
SLDB
$420M
| $9.8M | ﹤0.01% |
1,728,065
+994,984
| +136% | +$5.64M |
|
1380
Collegium Pharmaceutical
COLL
$1.18B
| $9.78M | ﹤0.01% |
303,870
+110,499
| +57% | +$3.56M |
|
1381
Assured Guaranty
AGO
$3.93B
| $9.77M | ﹤0.01% |
126,673
+94,486
| +294% | +$7.29M |
|
1382
CureVac
CVAC
$1.2B
| $9.77M | ﹤0.01% |
2,872,919
+111,829
| +4% | +$380K |
|
1383
Evolus
EOLS
$465M
| $9.76M | ﹤0.01% |
899,377
-36,996
| -4% | -$401K |
|
1384
Fastenal
FAST
$54.5B
| $9.74M | ﹤0.01% |
310,018
+291,554
| +1,579% | +$9.16M |
|
|
HUT
1385
Hut 8
HUT
$3.42B
| $9.73M | ﹤0.01% |
649,518
+205,836
| +46% | +$3.08M |
|
1386
PTC Therapeutics
PTCT
$4.85B
| $9.71M | ﹤0.01% |
317,579
+175,289
| +123% | +$5.36M |
|
1387
CMS Energy
CMS
$21.5B
| $9.67M | ﹤0.01% |
162,449
-826,084
| -84% | -$49.2M |
|
1388
Genmab
GMAB
$17.1B
| $9.57M | ﹤0.01% |
380,995
-92,934
| -20% | -$2.34M |
|
1389
Descartes Systems
DSGX
$8.96B
| $9.57M | ﹤0.01% |
98,788
-10,831
| -10% | -$1.05M |
|
1390
A10 Networks
ATEN
$1.26B
| $9.56M | ﹤0.01% |
+690,412
| New | +$9.56M |
|
1391
MoonLake Immunotherapeutics
MLTX
$3.34B
| $9.54M | ﹤0.01% |
216,964
+195,989
| +934% | +$8.62M |
|
1392
Interparfums
IPAR
$3.43B
| $9.52M | ﹤0.01% |
82,032
-3,606
| -4% | -$418K |
|
1393
Woodside Energy
WDS
$30.5B
| $9.51M | ﹤0.01% |
505,380
+48,278
| +11% | +$908K |
|
1394
MSC Industrial Direct
MSM
$5.09B
| $9.49M | ﹤0.01% |
119,700
+98,265
| +458% | +$7.79M |
|
1395
Liberty Latin America Class C
LILAK
$1.53B
| $9.49M | ﹤0.01% |
986,782
+743,197
| +305% | +$7.15M |
|
1396
Coty
COTY
$3.57B
| $9.49M | ﹤0.01% |
946,939
-1,339,066
| -59% | -$13.4M |
|
1397
Tarsus Pharmaceuticals
TARS
$2.08B
| $9.47M | ﹤0.01% |
348,586
+322,942
| +1,259% | +$8.78M |
|
1398
ZIM Integrated Shipping Services
ZIM
$1.64B
| $9.44M | ﹤0.01% |
425,795
+262,200
| +160% | +$5.81M |
|
1399
Suncor Energy
SU
$50.6B
| $9.44M | ﹤0.01% |
247,728
+235,703
| +1,960% | +$8.98M |
|
1400
Schrodinger
SDGR
$1.37B
| $9.43M | ﹤0.01% |
487,831
+471,399
| +2,869% | +$9.12M |
|